Product Description
Composition Empagliflozin 25 mg IR
Indication: Type 2 diabetes mellitus (T2DM) to improve blood sugar control, Heart failure to reduce cardiovascular death and hospitalization, Chronic kidney disease (CKD) to slow progression and lower CV risk.